Anti–tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen b27–associated acute anterior uveitis
Authors:
- Yosuf El-ShabrawiYEYosuf El-Shabrawi
- Josef HermannJHJosef Hermann
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 109 (12) , 2342-2346
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Methotrexate therapy for chronic noninfectious uveitisOphthalmology, 2001
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- The Role of Cytokines and Chemokines in Uveitis1999
- Outcomes in anterior uveitis associated with the HLA-B27 haplotypeOphthalmology, 1998
- Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin ABritish Journal of Ophthalmology, 1997
- Report on the 4thInternational Symposium of Ocular InflammationOcular Immunology and Inflammation, 1997
- The possible impact of uveitis in blindness: a literature survey.British Journal of Ophthalmology, 1996
- Deactivation of vascular endothelium by monoclonal anti–tumor necrosis factor α antibody in rheumatoid arthritisArthritis & Rheumatism, 1996
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993